Source: Annual Congress 2011 - Instructive clinical aspects of lung cancer
Disease area: Thoracic oncology



Rating:

Share or cite this content

Citations should be made in the following way:
D. Misch, J. Kollmeier, S. Griff, C. Boch, K. Zimmermann, T. Blum, W. Grüning, T. Mairinger, T. Bauer (Berlin, Germany). TTF-1 in advanced SCLC – Diagnostic and prognostic relevance. Eur Respir J 2011; 38: Suppl. 55, 2809

Member's Comments

No comment yet.

Related content which might interest you: EGFR and hTERT mRNA expression in non-small cell lung cancer patients – Diagnostic and prognostic implications Source: Annual Congress 2010 - Biomarkers for lung cancer Year: 2010 Clinical and pathologic staging – PET/CT impact Source: Annual Congress 2010 - Staging of lung cancer Year: 2010 Lung cancer surgery and prognostic fators: c-erb-2, Ki-67 and β-Hcg Source: Eur Respir J 2003; 22: Suppl. 45, 212s Year: 2003 EGFR – a useful biomarker? Source: Annual Congress 2009 - Biological and clinical markers in lung cancer Year: 2009 Prognostic significance of three tumor markers (CA125, CEA, and TPA) in lung cancer Source: Eur Respir J 2002; 20: Suppl. 38, 73s Year: 2002 PET/CT in the preoperative staging of lung cancer – Case series Source: Annual Congress 2010 - Vascular and solitary lesions Year: 2010 Plasma levels of alpha crystalline antibodies in NSCLC patients – Diagnostic significance Source: Annual Congress 2010 - Biomarkers for lung cancer Year: 2010 Octogenarians with non-small cell lung carcinoma – Advanced disease Source: Annual Congress 2012 - Instructive clinical aspects of thoracic oncology Year: 2012 Metastasectomy – Benign aggression for patients with metastatic dissemination of colorectal cancer Source: Annual Congress 2010 - Diagnostic and therapeutic problems in surgical oncology Year: 2010 Multiple kinds of cancer in one person – Lung and breast cancer – And other malignant entities Source: Annual Congress 2010 - Thoracic malignancies: interesting case studies and series Year: 2010 LATE-BREAKING ABSTRACT: Prognostic value of microRNAs expression in stage I-IIIA lung adenocarcinoma (AC) Source: Annual Congress 2013 –New strategies in epigenomic research to study lung diseases (DNA rearrangements, RNA, methylation, proteosome) Year: 2013 Clinical correlates and prognostic significance of neuron specific enolase (NSE) in non-small cell lung cancer (NSCLC) Source: Eur Respir J 2002; 20: Suppl. 38, 73s Year: 2002 Time in lung cancer diagnosis and its prognostic implication Source: International Congress 2018 – Lung cancer: risk factors, supportive measures and quality improvement Year: 2018 Tissue expression of alpha crystallins and plasma levels of antibodies against them in NSCLC patients – Prognostic significance Source: Annual Congress 2010 - Biomarkers for lung cancer Year: 2010 Prognostic significance of S-100 immmunostaining in non-small cell lung cancer (NSCLC) Source: Annual Congress 2004 - Prognostic factors Year: 2004 Detection of lung cancer on CXR – A comparison of radiologist‘s performance Source: Annual Congress 2010 - Quality management for lung cancer patients Year: 2010 Evaluation of predictive and therapeutic value of WSX1/IL27 axis in non-small cell lung cancer (NSCLC) Source: International Congress 2015 – Cell biology of lung cancer and new biomarkers Year: 2015 Postoperative predicting value of lung function in patients with lung cancer – Fortune-telling or reality? Evaluation after surgical treatment Source: Annual Congress 2011 - Lung function today and tomorrow II Year: 2011 Lung cancer in Berlin – Therapeutic concepts and their impact on survival in patients with NSCLC stage II/III from 2000 to 2008 Source: Annual Congress 2012 - Treatment of lung cancer Year: 2012 EGFR and hTERT expression in high risk COPD patients – clinical application Source: Annual Congress 2009 - Biological and clinical markers in lung cancer Year: 2009